Infections in solid organ transplant recipients;Infecciones en pacientes sometidos a trasplante de órgano sólido

Revista de Investigacion Clinica

Volumn 57, Issue 2, 2005, Pages 368-380

  Cuellar Rodríguez, Jennifer ^a   Sierra Madero, Juan G ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Cytomegalovirus; Fungal infections; Transplant infections; Viral infections

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; GLUCOCORTICOID; INTERLEUKIN 2 RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY CD3; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ASPERGILLUS; BACTERIAL INFECTION; CANDIDA; CELLULAR IMMUNITY; CLINICAL FEATURE; CRYPTOCOCCUS NEOFORMANS; CYTOMEGALOVIRUS; FUNGAL STRAIN; GRAFT INFECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTESTINE TRANSPLANTATION; KIDNEY TRANSPLANTATION; LEGIONELLA; LISTERIA; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; MYCOBACTERIUM; MYCOSIS; NOCARDIA; NONHUMAN; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PARASITOSIS; PNEUMOCYSTIS; POSTOPERATIVE PERIOD; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; ZYGOMYCETES;

BACTERIAL INFECTIONS; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNOSUPPRESSION; INFECTION; INFECTION CONTROL; MYCOSES; OPPORTUNISTIC INFECTIONS; ORGAN SPECIFICITY; ORGAN TRANSPLANTATION; PARASITIC DISEASES; POSTOPERATIVE COMPLICATIONS; RISK; SURGICAL WOUND INFECTION; VIRUS ACTIVATION; VIRUS DISEASES;

EID: 25444436705     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Simon DM, Levin S. Infectious complications of solid organ transplantations. Infec Dis Clin North Am 2001; 15: 521.
2. Kirkiln JK, Naftel DC, Bourge RC, et al. Evolving trends in risk profiles and causes of death after heart transplantation: A ten year multi-institutional study. J Thorac Cardiovasc Surg 2003; 125: 881.
3. Dummer JS. Infectious in solid organ transplant recipients. In Mandell GL, Bennet JE, Dolin R (Eds.). Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone; 2005, p. 3501-12.
4. Fishman JA, Rubin RH. Infection in organ-transplant recipient. N Engl J Med 1998; 338: 1741.
5. Gottesdiener KM. Transplanted infections: Donor-to-host transmission with the allograft. Ann Intern Med 1989; 110: 1001.
6. Rubin RH, Tolkoff-Rubin NE. Risks and epidemiology of infections after renal transplantation. In: Bowden RA, Ljungman P, Paya CV (Eds.). Transplant Infections. Philadelphia: Lippincott Williams & Wilkins; 2003, p. 99-119.
7. Maurer JR, Tullius E, Grossman RF, et al. Infectious complications following lung transplantation. Chest 1992; 101: 1056.
8. Gavalda J, Román A, Pahissa A. Risks and epidemiology of infections after lung or heart-lung transplantation. In: Bowden RA, Ljungman P, Paya CV (Eds.). Transplant infections. Philadelphia: Lippincott, Williams & Wilkins; 2003, p. 63-85.
9. Soave R. Prophylaxis strategies for solid-organ transplantation. Clin Infect Dis 2001; 33(Suppl 1): S26.
10. Singh N. Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients. Lan Infect Dis 2003; 3(3):156.
11. Singh N, Paterson DL. Aspergillus infections in transplants recipients. Clin Microbiol Rev 2005; 18(1): 44.
12. Kwak EJ, Vilchez RA, Randhawa P, et al. Pathogenesis and management of poliomavirus infection in transplant patients. Clin Infect Dis 2002; 35: 1081.
13. Snydman D. Epidemiology of infections after solid organ transplantation. Clin Infec Dis 2001; 33(Suppl. 1): S5.
14. Kwak EJ, Kusme S. Risks and epidemiology of infections after Liver transplantation. In: Bowden RA, Ljungman P, Paya CV (Eds.). Transplant Infections. Philadelphia: Lippincott Williams & Wilkins; 2003, p. 120-31.
15. Avery RK. Prophylactic strategies before solid organ transplantation. Curr Op Infect Dis 2004; 17: 353.
16. Rodríguez-Luna H, Douglas DD. Natural history of hepatitis C following liver transplantation. Curr Op Infect Dis 2004; 17: 363.
17. Keay S. Risks and epidemiology of infections after heart transplantation. In: Bowden RA, Ljungman P, Paya CV (Eds.). Transplant infections. Philadelphia: Lippincott Williams & Wilkins; 2003, p. 51-62.
18. Humar A, Humar A. Risks and epidemiology of infections after pancreas or kidney-pancreas transplantation. In: Bowden RA, Ljungman P, Paya CV (Eds.). Transplant Infections. Philadelphia: Lippincott Williams & Wilkins; 2003, p. 86-98.
19. Reyes J, Green M. Risks and epidemiology of infections after intestinal transplantation. In: Bowden RA, Ljungman P, Paya CV (Eds.). Transplant Infections. Philadelphia: Lippincott Williams & Wilkins; 2003, p. 132-9.
20. Preiksaitis J, Keay S. Diagnosis and management of postransplant lymphoproliferative disorder in solid-organ transplant recipients. Clin Infect Dis 2001; 33(Suppl. 1): S38.
21. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am 2003; 17(1): 113.
22. Dummer JS. Risk factors and approaches to infections in transplant recipients. In: Mandell GL, Bennet JE, Dolin R (Eds.). Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2005, p. 3476-86.
23. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid organ transplant recipients: Impact and implications for management. Clin Infect Dis 1998; 27: 1266.
24. Pereyra F, Rubin RH. Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Curr Op Infect Dis 2004; 17: 357.
25. Paya C, Razonable RR. Cytomegalovirus infection after solid organ transplantation. In: Bowden RA, Ljungman P, Paya CV (Eds.). Transplant infections. Philadelphia: Lippincott Williams & Wilkins; 2003, p. 298-325.
26. Taber DJ, Ashcraft E, Baillie GM. Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Trans Infect Dis 2004; 6: 101.
27. Mayorga H, Gonzalez Michaca L, Cuellar JV, et al. CMV antigenemia is not associated with adverse graft outcome or CMV disease in intermediate risk transplant recipients. P 806 XX International congress of the transplantation society September 2004.